| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 12,182,426,267.1 | 81,181,289,583.46 | 55,521,300,144.69 | 35,794,318,909.02 |
| 收到的税费返还 | 63,285,021.05 | 418,991,872.39 | 286,535,940.14 | 145,696,849.42 |
| 收到其他与经营活动有关的现金 | 802,864,300 | 3,818,607,345.58 | 2,889,098,364.14 | 1,720,102,496.55 |
| 经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动现金流入小计 | 13,048,575,588.15 | 85,418,888,801.43 | 58,696,934,448.97 | 37,660,118,254.99 |
| 购买商品、接受劳务支付的现金 | 9,073,027,991.16 | 53,198,864,860.71 | 40,234,323,619.94 | 25,577,521,035.07 |
| 支付给职工以及为职工支付的现金 | 2,607,905,313.48 | 9,193,702,328.18 | 7,191,016,443.92 | 5,022,887,415.18 |
| 支付的各项税费 | 1,767,317,940.23 | 6,977,399,883.88 | 4,842,131,496.05 | 3,402,920,028.01 |
| 支付其他与经营活动有关的现金 | 1,759,630,018.51 | 3,588,546,933.53 | 3,048,179,885.58 | 2,132,427,570.35 |
| 经营活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动现金流出小计 | 15,207,881,263.38 | 72,958,514,006.3 | 55,315,651,445.49 | 36,135,756,048.61 |
| 经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动产生的现金流量净额 | -2,159,305,675.23 | 12,460,374,795.13 | 3,381,283,003.48 | 1,524,362,206.38 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 0 | 104,019,626.3 | 3,750,000 | 3,750,000 |
| 取得投资收益收到的现金 | 0 | 272,529,207.12 | 168,424,397.02 | 65,039,331.62 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 249,812,425.05 | 587,451,558.19 | 506,013,867.07 | 437,187,940.61 |
| 处置子公司及其他营业单位收到的现金净额 | 0 | 252,405,033.48 | 3,318,953.75 | 3,318,953.75 |
| 收到的其他与投资活动有关的现金 | 84,406,483.6 | 169,852,108.38 | 156,954,417.55 | 156,954,417.55 |
| 投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动现金流入小计 | 334,218,908.65 | 1,386,257,533.47 | 838,461,635.39 | 666,250,643.53 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 2,020,654,840.3 | 9,135,254,295.44 | 7,156,710,384.97 | 4,744,748,252.4 |
| 投资支付的现金 | 428,982,352.94 | 9,827,466.18 | 1,572,200 | 1,572,200 |
| 质押贷款净增加额 | - | - | - | 0 |
| 取得子公司及其他营业单位支付的现金 | 911,683,253 | 914,607,377.44 | 914,601,534.52 | 914,601,534.52 |
| 支付其他与投资活动有关的现金 | 0 | 57,464,651.78 | 14,060,927.21 | 10,900,584.35 |
| 投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动现金流出小计 | 3,361,320,446.24 | 10,117,153,790.84 | 8,086,945,046.7 | 5,671,822,571.27 |
| 投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动产生的现金流量净额 | -3,027,101,537.59 | -8,730,896,257.37 | -7,248,483,411.31 | -5,005,571,927.74 |
| 三、筹资活动产生的现金流量: | | | | |
| 吸收投资收到的现金 | 109,297,230 | 1,452,155,500 | 937,443,900 | 931,193,900 |
| 其中:子公司吸收少数股东投资收到的现金 | 109,297,230 | 1,452,155,500 | 937,443,900 | 931,193,900 |
| 取得借款收到的现金 | 17,568,207,427.48 | 55,606,980,964.64 | 42,757,309,193.63 | 33,686,530,476.63 |
| 收到其他与筹资活动有关的现金 | 5,362,254,217.71 | 16,768,604,665.2 | 10,842,015,441.36 | 8,320,115,441.36 |
| 筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动现金流入小计 | 23,039,758,875.19 | 73,827,741,129.84 | 54,536,768,534.99 | 42,937,839,817.99 |
| 偿还债务支付的现金 | 8,630,666,674.76 | 52,931,342,960.93 | 30,336,364,329.7 | 25,017,709,558.7 |
| 分配股利、利润或偿付利息支付的现金 | 1,006,766,584.5 | 4,564,928,574.61 | 3,988,613,982.5 | 2,731,193,472.76 |
| 其中:子公司支付给少数股东的股利、利润 | 167,142,414.36 | 485,187,312.05 | 337,298,084.62 | 283,884,217.05 |
| 支付其他与筹资活动有关的现金 | 7,066,055,042.62 | 22,165,673,854.42 | 16,622,328,200.83 | 12,839,162,697.31 |
| 筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 16,703,488,301.88 | 79,661,945,389.96 | 50,947,306,513.03 | 40,588,065,728.77 |
| 筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动产生的现金流量净额 | 6,336,270,573.31 | -5,834,204,260.12 | 3,589,462,021.96 | 2,349,774,089.22 |
| 四、汇率变动对现金及现金等价物的影响 | -3,431,303.93 | -7,496,228.3 | -68,858,393.07 | 2,797,943.28 |
| 现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
| 五、现金及现金等价物净增加额 | 1,146,432,056.56 | -2,112,221,950.66 | -346,596,778.94 | -1,128,637,688.86 |
| 加:期初现金及现金等价物余额 | 9,655,719,488.45 | 11,743,296,045.53 | 11,743,296,045.53 | 11,743,296,045.53 |
| 期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
| 期末现金及现金等价物余额 | 10,802,151,545.01 | 9,631,074,094.87 | 11,396,699,266.59 | 10,614,658,356.67 |
| 补充资料: | | | | |
| 净利润 | - | -650,580,298.52 | - | -3,727,758,546.39 |
| 资产减值准备 | - | 421,848,245.41 | - | 148,916,155.75 |
| 固定资产和投资性房地产折旧 | - | 7,697,487,470.64 | - | 3,915,895,563.54 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 7,697,487,470.64 | - | 3,915,895,563.54 |
| 无形资产摊销 | - | 2,056,196,193.04 | - | 964,247,826.41 |
| 长期待摊费用摊销 | - | 813,650,925.07 | - | 441,348,100.77 |
| 处置固定资产、无形资产和其他长期资产的损失 | - | -635,647,968.75 | - | -7,508,634.77 |
| 固定资产报废损失 | - | 10,473,884.39 | - | 2,309,685.4 |
| 公允价值变动损失 | - | -98,935,819.99 | - | -29,859,760.42 |
| 财务费用 | - | 3,490,857,036.74 | - | 1,887,594,837.8 |
| 投资损失 | - | -15,922,256.43 | - | 142,920,557.53 |
| 递延所得税 | - | -366,730,122.73 | - | -197,038,348.24 |
| 其中:递延所得税资产减少 | - | -333,200,911.24 | - | -173,645,738.97 |
| 递延所得税负债增加 | - | -33,529,211.49 | - | -23,392,609.27 |
| 存货的减少 | - | 3,143,481,145.98 | - | -361,713,318 |
| 经营性应收项目的减少 | - | -1,463,681,084.63 | - | -3,660,123,295.96 |
| 经营性应付项目的增加 | - | -2,234,563,500.71 | - | 1,882,824,296.85 |
| 现金的期末余额 | - | 9,631,074,094.87 | - | 10,614,658,356.67 |
| 减:现金的期初余额 | - | 11,743,296,045.53 | - | 11,743,296,045.53 |
| 公告日期 | 2025-04-24 | 2025-03-27 | 2024-10-26 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |